companydata.dkcompanydata.dk

MedTrace Pharma A/S: Financial statements 2022

CVR: 36497661

Source: annual report 2022, Danish Business Authority

01/01/2022 – 31/12/2022

MedTrace Pharma A/S (CVR 36497661) has filed annual accounts for 2022. In 2022, the company reported revenue of DKK 2,192,838 and a net result of DKK -37,035,484 compared with DKK -17,851,683 the year before. That is an increase of 43.4% compared with the year before. The profit margin was -1,688.9%. Equity in the 2022 report amounted to DKK 161,190,573. The solvency ratio was 84.5%. The company had 29 employees in the financial year.

Revenue
DKK 2,192,838
Gross Profit
DKK 1,923,261
Profit/Loss
DKK -37,035,484
Equity
DKK 161,190,573
Total Assets
DKK 190,684,722
Employees
29

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
20222.2 mio.1.9 mio.-37 mio.161.2 mio.29
20211.5 mio.374 t.-17.9 mio.93.7 mio.-
2020-3 mio.1.2 mio.34.6 mio.5
2019-1.1 mio.-1 mio.5.7 mio.5
2018--68 t.-1.2 mio.6.7 mio.5

Official annual report

View the official annual report directly on the page with a Pro subscription.

Keep an eye on MedTrace Pharma A/S

Get notified instantly about new financial statements, ownership changes, management changes and status changes.

Set up monitoring

Events in 2022

Martin Dal Stenfeldt steps down as adm. dir. of MedTrace Pharma A/SDec 19, 2022

As of December 19, 2022, Martin Dal Stenfeldt has stepped down as adm. dir. of MedTrace Pharma A/S.

Claus Henrik Berner Møller joins the board of MedTrace Pharma A/SDec 14, 2022

As of December 14, 2022, Claus Henrik Berner Møller has joined the board of directors of MedTrace Pharma A/S.

Erik Anders Strömqvist joins the board of MedTrace Pharma A/SDec 14, 2022

As of December 14, 2022, Erik Anders Strömqvist has joined the board of directors of MedTrace Pharma A/S.

Erik Anders Strömqvist joins MedTrace Pharma A/S as adm. dir.Dec 14, 2022

As of December 14, 2022, Erik Anders Strömqvist is registered as adm. dir. of MedTrace Pharma A/S.

Claus Henrik Berner Møller leaves the board of MedTrace Pharma A/SDec 13, 2022

As of December 13, 2022, Claus Henrik Berner Møller has left the board of directors of MedTrace Pharma A/S.

Erik Anders Strömqvist leaves the board of MedTrace Pharma A/SDec 13, 2022

As of December 13, 2022, Erik Anders Strömqvist has left the board of directors of MedTrace Pharma A/S.

MedTrace Pharma A/S: The 2021 annual report is outJun 16, 2022

MedTrace Pharma A/S has published its annual report for 2021. Revenue came to DKK 1,529,103, and the net result was DKK -17,851,683.

Ann Kristin Brøgger Led joins MedTrace Pharma A/S as directorApr 1, 2022

As of April 1, 2022, Ann Kristin Brøgger Led is registered as director of MedTrace Pharma A/S.

About MedTrace Pharma A/S

MedTrace Pharma A/S is a Danish company of the type Aktieselskab based in Hørsholm, founded in 2015. The company is registered under the industry Udlejning og leasing af andet materiel, udstyr og andre materielle aktiver til events. The company was previously named MedTrace A/S and Medtrace ApS. The management consists of Peter Juul Kristensen and Lykke Jul Rømer. The board consists of Erik Anders Strömqvist (chair), Cesare Orlandi, Charlotte Vindfeldt and Claus Henrik Berner Møller. The company's owners include Arbejdsmarkedets Tillægspension, MedTravest IV ApS and Swisscanto Private Equity I KmGK. The company has 32 employees (2026). In 2025, the company reported revenue of DKK 1,759,371 and a net result of DKK -35,131,112 compared with DKK -15,355,876 the year before. Equity in the 2025 report amounted to DKK 302,613,643.

Source: annual report 2025, Danish Business Authority